Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program

Go back to Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
(NASDAQ: ACHV) Delayed: 7.96 +0.54 (7.28%)
Previous Close $7.42    52 Week High
Open $7.59    52 Week Low
Day High $8.11    P/E N/A 
Day Low $7.59    EPS
Volume 788,111